Capital Flow Monitor · Sponsors · CIK 2036372

OptoVista Holdings, LLC

C/O Tern Therapeutics, 1200 G STREET, NW, WASHINGTON, DC, 20005 · 703-919-6983

Biotechnology · Limited Liability Company· inc. DELAWARE true 2023

Fit score

—

Offering

$3.7M

Sold

$3.7M

% sold

100.0%

Investors

7

Min investment

$0

Exemption

506(c)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2026-09-25 D ·current 506(c) $3.7M $3.7M 100.0% 7 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.

  • Matthew Michael Rosini — Executive Officer, Washington, DC
  • Alexander Bailey — Executive Officer / Director, Washington, DC
  • Christina Ohnsman — Executive Officer, Washington, DC
  • Steven Oliveira — Director, Washington, DC
  • Kerry Propper — Director, Washington, DC
    2 other raises

Placement agents

  • No sales compensation reported — direct raise.

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.